Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)

Carta Revisado por pares

Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)

2014; Oxford University Press; Volume: 171; Issue: 2 Linguagem: Inglês

10.1111/bjd.12948

ISSN

1365-2133

Autores

Kohei Ogawa, Hannah Leah Morito, A. Hasegawa, Fumi Miyagawa, Nobuhiko Kobayashi, Hideaki Watanabe, Hirohiko Sueki, Mikiko Tohyama, Koji Hashimoto, Yoko Kano, Tetsuo Shiohara, Kenichi Ito, Hiroyuki Fujita, Michiko Aihara, Hideo Asada,

Tópico(s)

Urticaria and Related Conditions

Resumo

British Journal of DermatologyVolume 171, Issue 2 p. 425-427 Correspondence Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS) K. Ogawa, K. Ogawa Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 JapanSearch for more papers by this authorH. Morito, H. Morito Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 JapanSearch for more papers by this authorA. Hasegawa, A. Hasegawa Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 JapanSearch for more papers by this authorF. Miyagawa, F. Miyagawa Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 JapanSearch for more papers by this authorN. Kobayashi, N. Kobayashi Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 JapanSearch for more papers by this authorH. Watanabe, H. Watanabe Department of Dermatology, Showa University School of Medicine, Tokyo, JapanSearch for more papers by this authorH. Sueki, H. Sueki Department of Dermatology, Showa University School of Medicine, Tokyo, JapanSearch for more papers by this authorM. Tohyama, M. Tohyama Department of Dermatology, Ehime University Graduate School of Medicine, Matsuyama, JapanSearch for more papers by this authorK. Hashimoto, K. Hashimoto Department of Dermatology, Ehime University Graduate School of Medicine, Matsuyama, JapanSearch for more papers by this authorY. Kano, Y. Kano Department of Dermatology, Kyorin University School of Medicine, Tokyo, JapanSearch for more papers by this authorT. Shiohara, T. Shiohara Department of Dermatology, Kyorin University School of Medicine, Tokyo, JapanSearch for more papers by this authorK. Ito, K. Ito Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, JapanSearch for more papers by this authorH. Fujita, H. Fujita Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, JapanSearch for more papers by this authorM. Aihara, M. Aihara Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, JapanSearch for more papers by this authorH. Asada, Corresponding Author H. Asada Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 Japan Correspondence: Hideo Asada. E-mail: asadah@naramed-u.ac.jpSearch for more papers by this author K. Ogawa, K. Ogawa Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 JapanSearch for more papers by this authorH. Morito, H. Morito Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 JapanSearch for more papers by this authorA. Hasegawa, A. Hasegawa Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 JapanSearch for more papers by this authorF. Miyagawa, F. Miyagawa Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 JapanSearch for more papers by this authorN. Kobayashi, N. Kobayashi Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 JapanSearch for more papers by this authorH. Watanabe, H. Watanabe Department of Dermatology, Showa University School of Medicine, Tokyo, JapanSearch for more papers by this authorH. Sueki, H. Sueki Department of Dermatology, Showa University School of Medicine, Tokyo, JapanSearch for more papers by this authorM. Tohyama, M. Tohyama Department of Dermatology, Ehime University Graduate School of Medicine, Matsuyama, JapanSearch for more papers by this authorK. Hashimoto, K. Hashimoto Department of Dermatology, Ehime University Graduate School of Medicine, Matsuyama, JapanSearch for more papers by this authorY. Kano, Y. Kano Department of Dermatology, Kyorin University School of Medicine, Tokyo, JapanSearch for more papers by this authorT. Shiohara, T. Shiohara Department of Dermatology, Kyorin University School of Medicine, Tokyo, JapanSearch for more papers by this authorK. Ito, K. Ito Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, JapanSearch for more papers by this authorH. Fujita, H. Fujita Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, JapanSearch for more papers by this authorM. Aihara, M. Aihara Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, JapanSearch for more papers by this authorH. Asada, Corresponding Author H. Asada Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo-cho, Kashihara, Nara, 634-8522 Japan Correspondence: Hideo Asada. E-mail: asadah@naramed-u.ac.jpSearch for more papers by this author First published: 06 March 2014 https://doi.org/10.1111/bjd.12948Citations: 31 Funding sources: This study was partly supported by Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour, and Welfare of Japan and KAKENHI (to H.A., no. 23591650). Conflicts of interest: none declared. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume171, Issue2August 2014Pages 425-427 RelatedInformation

Ver no editor

Altmetric

PlumX

Entrar

Lembrar minha senha

Receber meu e-mail de confirmação

Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)